港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

抗疫概念

976.811

+21.9542.30%

漲家數：17

跌家數：1

平家數：- -

市盈率：- -

高：984.418

開：954.770

低：954.770

收：954.857

資料載入中...

總覽新聞資訊

港股三大指數午後漲幅擴大恒指全日漲3.29% 快手(01024)升15.7%

美股“七姐妹”讓位！中國科技巨頭價值重估正在展開

【拓新藥業：全資子公司奧拉帕利原料藥獲得上市申請批准通知書】拓新藥業(301089.SZ)公告稱，公司全資子公司新鄉製藥股份有限公司的奧拉帕利原料藥收到國家藥品監督管理局簽發的《化學原料藥上市申請批准通知書》，並批准註冊。奧拉帕利主要用於治療攜帶胚系或體系BRCA突變的晚期上皮性卵巢癌、輸卵管癌或原發性腹膜癌。此次批准將豐富公司產品線，提升市場競爭力，對國內市場產生積極影響。但需注意醫藥產品銷售受市場、政策、環境變化等不確定因素影響，存在銷售不達預期的風險。

時代電氣：2024年全年公司裝機量約225.56萬個，僅次於比亞迪排名第2

比亞迪鴻蒙智行之後，極氪也出手“打黑”：最高懸賞五百萬！

南方都市报

完成處置超20億元！復星醫藥市值腰斬，聚焦核心業務

深圳商报·读创

56億美元！萬億比亞迪再融資背後，亟待降槓桿

Ofweek维科网

同源康醫藥-B盤中異動下午盤股價大跌6.45%報29.000港元

醫藥外包概念股集體走強維亞生物漲6.77% 機構指AI技術滲透加速CXO產業範式革新

稀缺科創生物醫藥新股！全球競爭優勢明顯，利潤3年翻了近四倍

徐冠巨代表：及時修訂《國民經濟行業分類》，納入新興產業

汽車價格戰暫停的信號，可能要來了？

Ofweek光电信息网

復星醫藥(02196)1類肺癌新藥申報上市顱內客觀緩解率可達100%

京東健康盤中異動早盤快速上漲3.10%

港股創新藥ETF漲超2.5%，來凱醫藥-B漲超11%，機構：具有高科技屬性的醫藥醫療公司將更受市場青睞

21世纪经济报道

港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式產品發展未來可期

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1515/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":976.81055,"timestamp":1741248510324,"preClose":954.8568,"halted":0,"volume":575283040,"delay":0,"changeRate":0.022992,"change":21.953735,"pbRate":1.681623,"amount":5623531621,"amplitude":0.03105,"prevYearClose":787.97723,"fiveDayClose":966.408,"twentyDayClose":851.934,"turnoverRate":0.007641,"marketCap":671721238880,"floatMarketCap":554131605088,"peRate":21.189191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":984.418,"amplitude":0.03105,"preClose":954.8568,"low":954.7698,"pbRate":"1.681623","latestPrice":976.81055,"volume":575283040,"delay":0,"open":954.7698,"prevYearClose":787.97723,"prevWeekClose":904.791,"prevMonthClose":904.791,"prevQuarterClose":787.977,"fiveDayClose":966.408,"twentyDayClose":851.934,"sixtyDayClose":807.806,"secType":"PLATE","market":"HK","turnoverRate":0.007641,"peRate":21.189191,"marketCap":671721238880,"floatMarketCap":554131605088,"timestamp":1741248510324,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":17,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517387531","title":"港股三大指數午後漲幅擴大 恒指全日漲3.29% 快手(01024)升15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517387531","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517387531?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:18","pubTimestamp":1741249088,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数午后涨幅扩大，全日高开高走，截至收盘，恒指涨3.29%，国企指数涨3.57%，恒生科技指数涨5.40%。浦银国际发研报指，今年1月下旬以来，DeepSeek的关注度迅速提升。该行续指，中国互联网龙头加强AI的战略地位，提升AI的资本开支并有望较此前翻倍。该行表示，DeepSeek的创新有望缓解美对中在半导体，尤其是AI算力的限制所带来的压力。个股方面，蜜雪集团涨14.95%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d98b2609bc10558b50734bda5cfc045c","theme_name":"🔥熱榜No.1 · 恆生指數和恆生科技指數創收盤新高","theme_type":2,"isJumpTheme":false,"source_url":"1954523","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HHImain","LU0868486357.SGD","00669","00001","LU0348767384.USD","HSCEI","00881","LU0149721374.USD","LU2097828631.EUR","BK1608","00285","LU1481107354.HKD","HSI","LU0164880469.USD","00836","LU2097828714.EUR","LU0106259558.USD","01024","HSTECH","MHImain","LU0572944931.SGD","BK1515","HSImain","SG9999011746.SGD","BK1591","MCHmain","LU0828237510.HKD","LU0164865239.USD","LU1794554557.SGD","YANG","LU1251922891.USD","BK1520","89618","IE0008368411.USD","IE0009570106.USD","81024","LU1808992512.USD","LU2097828805.USD","LU1282649067.USD","LU0048580855.USD","02833","513600","LU0227179875.USD","LU0865486749.SGD","LU0029875118.USD","BK1249","LU0072462343.USD"],"gpt_icon":1},{"id":"2517138107","title":"美股“七姐妹”讓位！中國科技巨頭價值重估正在展開","url":"https://stock-news.laohu8.com/highlight/detail?id=2517138107","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517138107?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 16:13","pubTimestamp":1741248811,"startTime":"0","endTime":"0","summary":"目前，美国科技“七姐妹”总市值已接近16万亿美元，超过了日本、德国、英国和印度股市的市值总和。比亚迪全民智驾战略的发布，更是让全球资本对中国科技股刮目相看。随后，包括华泰、海通在内的多家券商发布中国科技“七姐妹”名单，比亚迪、阿里巴巴、联想、美团、中芯国际、腾讯及小米，被视为可比肩美国“七姐妹”的科技巨头。今年以来，中国科技“七姐妹”股价走势明显跑赢美国科技“七姐妹”，共同推动新一轮全球科技革新。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306162209963be581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306162209963be581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2360107325.USD","LU0708995583.HKD","SG9999015986.USD","BK1582","BYDDY","LU2249611893.SGD","BK1515","LU0359202008.SGD","LU0307460666.USD","BK1522","BK1540","BK1539","01211","81211","00285","HYDD.SI","LU0348735423.USD","LU0516422366.SGD","LU0531970944.HKD","LU1868837565.USD","LU2348774022.SGD","SG9999015945.SGD","LU0516423091.SGD","LU2097828557.USD","002594","SG9999002463.SGD","LU2097828631.EUR","BK1589","BK1119","LU0143863784.USD","LU0449515922.USD","SG9999006597.SGD","SG9999014674.SGD","LU0856984785.SGD","LU0254981946.USD","LU1808992512.USD","LU0516423174.USD","LU1861214812.USD","BK1580","LU1861219969.SGD","LU0214875030.USD","LU0289961442.SGD","LU0417516738.SGD","BK1149","LU0052750758.USD","SG9999006514.SGD","SG9999015978.USD","LU0823426480.USD","LU0320764599.SGD","BK1610"],"gpt_icon":0},{"id":"2517182501","title":"【拓新藥業：全資子公司奧拉帕利原料藥獲得上市申請批准通知書】拓新藥業(301089.SZ)公告稱，公司全資子公司新鄉製藥股份有限公司的奧拉帕利原料藥收到國家藥品監督管理局簽發的《化學原料藥上市申請批准通知書》，並批准註冊。奧拉帕利主要用於治療攜帶胚系或體系BRCA突變的晚期上皮性卵巢癌、輸卵管癌或原發性腹膜癌。此次批准將豐富公司產品線，提升市場競爭力，對國內市場產生積極影響。但需注意醫藥產品銷售受市場、政策、環境變化等不確定因素影響，存在銷售不達預期的風險。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517182501","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517182501?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:45","pubTimestamp":1741247149,"startTime":"0","endTime":"0","summary":"拓新药业(301089.SZ)公告称，公司全资子公司新乡制药股份有限公司的奥拉帕利原料药收到国家药品监督管理局签发的《化学原料药上市申请批准通知书》，并批准注册。奥拉帕利主要用于治疗携带胚系或体系BRCA突变的晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌。此次批准将丰富公司产品线，提升市场竞争力，对国内市场产生积极影响。但需注意医药产品销售受市场、政策、环境变化等不确定因素影响，存在销售不达预期的风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06154548559054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301089","01477","09939","BK1515","BK1161","BK0239","BK1574","159938","BK1191"],"gpt_icon":0},{"id":"2517823771","title":"時代電氣：2024年全年公司裝機量約225.56萬個，僅次於比亞迪排名第2","url":"https://stock-news.laohu8.com/highlight/detail?id=2517823771","media":"互动易","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517823771?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:36","pubTimestamp":1741246574,"startTime":"0","endTime":"0","summary":"有投资者向时代电气提问， 公司IGBT产品有供应给比亚迪和小鹏么？公司回答表示，尊敬的投资者您好！根据NE时代近期发布的关于乘用车功率模块装机量的统计，2024年全年公司装机量约225.56万个，仅次于比亚迪排名第2，市场份额约13.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306154637a2620a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306154637a2620a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348767384.USD","SG9999014674.SGD","LU0052750758.USD","LU0449509016.USD","SG9999006514.SGD","IE0032431581.USD","LU0516422440.USD","SG9999015952.SGD","LU0531970944.HKD","LU0979878070.USD","LU0708995583.HKD","LU0511384066.AUD","LU0449515922.USD","LU1868837565.USD","LU0211977185.USD","LU0175139822.USD","LU0823426480.USD","002594","BK1594","LU0164872284.USD","BYDDY","LU0143863198.USD","LU0516423174.USD","LU2360107325.USD","LU0588546209.SGD","BK1540","LU2097828557.USD","SG9999002463.SGD","81211","BK1509","BK1119","LU0054450605.USD","01211","LU1868838027.USD","LU0856984785.SGD","LU0417516738.SGD","LU2476274308.USD","BK1149","HYDD.SI","LU0214875030.USD","LU1242518931.SGD","LU0516423091.SGD","LU0320764599.SGD","LU0274383008.USD","BK1515","00285","BK1565","LU0823426308.USD","LU0254981946.USD","03898"],"gpt_icon":0},{"id":"2517187814","title":"比亞迪鴻蒙智行之後，極氪也出手“打黑”：最高懸賞五百萬！","url":"https://stock-news.laohu8.com/highlight/detail?id=2517187814","media":"南方都市报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517187814?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:30","pubTimestamp":1741246230,"startTime":"0","endTime":"0","summary":"3月6日，极氪法务部通过微博发布《关于极氪企业名誉权维护及悬赏打黑的声明》（以下简称《声明》），表示将以公开招标形式向全社会招募名誉权维护专业机构，并悬赏至高500万元向社会征集黑公关和网络水军线索证据。《声明》显示，极氪方面注意到互联网各类内容及社交平台上，出现集中性、有策划、有组织地对极氪品牌、产品、高管及员工进行恶意贬低、拉踩、诋毁和人身攻击的相关内容。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338466716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2476274308.USD","LU2097828557.USD","LU2778985437.USD","LU1242518857.USD","LU0516422440.USD","HYDD.SI","LU0175139822.USD","LU0320764599.SGD","00285","LU2348774022.SGD","SG9999001226.SGD","LU0289739343.SGD","LU2097828714.EUR","LU0856984785.SGD","LU0307460666.USD","BK1589","LU0449509016.USD","002594","LU0143863198.USD","81211","LU0593848301.USD","LU0823426480.USD","LU2153592121.USD","BK1515","LU0289961442.SGD","BK1504","BK1522","LU0819121731.USD","SG9999002463.SGD","LU0823426308.USD","BYDDY","LU0417516738.SGD","LU1808992512.USD","BK1509","LU1861214812.USD","LU0449515922.USD","SG9999015945.SGD","LU0359202008.SGD","LU0516422366.SGD","BK1540","LU0359201612.USD","LU0348766576.USD","LU0708995583.HKD","LU0516423174.USD","LU0348735423.USD","LU2360107325.USD","LU0348805143.USD","IE00BD6J9T35.USD"],"gpt_icon":1},{"id":"2517181640","title":"完成處置超20億元！復星醫藥市值腰斬，聚焦核心業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2517181640","media":"深圳商报·读创","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517181640?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 15:16","pubTimestamp":1741245397,"startTime":"0","endTime":"0","summary":"近日，针对投资者关于股价表现及公司收购和对外担保等问题，复星医药（600196）在互动平台表示，公司已将业务重点聚焦于创新药和高值器械领域，通过加强自主研发与外部合作，丰富产品管线并强化全球化布局。此外，公司持续提升运营效率和资产效率，加速现金回流。2024年前8个月已完成处置及已签约待收回的处置总额超20亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338458911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1191","BK1593","02196"],"gpt_icon":0},{"id":"2517118510","title":"56億美元！萬億比亞迪再融資背後，亟待降槓桿","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118510","media":"Ofweek维科网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517118510?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 14:38","pubTimestamp":1741243088,"startTime":"0","endTime":"0","summary":"启动大手笔再融资背后，万亿比亚迪打算干什么？融资56亿美元，意欲何为3月4日，比亚迪、比亚迪股份均大幅下挫，放量下跌，分别收跌5.6%、6.77%，这源于公司披露的一则巨额融资公告。显而易见，比亚迪亟待降低杠杆，这也是上述融资目的之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306143835989e2e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306143835989e2e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1539","LU0052750758.USD","BK1607","LU0449509016.USD","IE00BD6J9T35.USD","LU2097828474.EUR","SG9999015952.SGD","LU0516422440.USD","LU0531970944.HKD","LU0289961442.SGD","LU0708995583.HKD","LU0511384066.AUD","LU2778985437.USD","LU0307460666.USD","002594","LU1868837722.USD","LU0164872284.USD","BYDDY","LU0143863198.USD","LU0348805143.USD","LU0516423174.USD","LU2097828631.EUR","LU2249611893.SGD","SG9999001226.SGD","LU2360107325.USD","SG9999015945.SGD","BK1540","LU0359201612.USD","LU2097828805.USD","81211","BK1509","BK1119","01211","LU0819123356.HKD","LU0856984785.SGD","LU2476274308.USD","BK1149","BK1610","HYDD.SI","LU0516423091.SGD","LU1808992512.USD","BK1522","BK1582","LU0274383008.USD","LU1242518857.USD","BK1515","00285","LU0979878070.USD","BK1589","LU0254981946.USD"],"gpt_icon":1},{"id":"2517186478","title":"同源康醫藥-B盤中異動 下午盤股價大跌6.45%報29.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517186478?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 14:23","pubTimestamp":1741242194,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘14时23分，同源康医药-B股票出现波动，股价急速跳水6.45%。截至发稿，该股报29.000港元/股，成交量39.85万股，换手率0.11%，振幅9.52%。资金方面，该股资金流入665.168万港元，流出549.195万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.51%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306142314abeada0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1161","BK1574","09939"],"gpt_icon":0},{"id":"2517512188","title":"醫藥外包概念股集體走強 維亞生物漲6.77% 機構指AI技術滲透加速CXO產業範式革新","url":"https://stock-news.laohu8.com/highlight/detail?id=2517512188","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517512188?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:48","pubTimestamp":1741240123,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股集体走强，截至发稿，维亚生物 涨6.77%，康龙化成涨3.92%，泰格医药和药明康德涨3.24%，药明生物涨2.38%消息面上，国泰君安发布研报称，AI技术渗透加速CXO产业范式革新。AI技术在生物医药领域深度应用有望重构CXO产业价值链。全球药企降本增效诉求升级，叠加AI技术成熟度提升，驱动CXO企业加速智能化转型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306134913963bb5f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1515","BK1161","03347","09939","BK1574","02359","01873","BK1141","03759"],"gpt_icon":0},{"id":"2517092188","title":"稀缺科創生物醫藥新股！全球競爭優勢明顯，利潤3年翻了近四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517092188","media":"海豚音","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517092188?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 13:21","pubTimestamp":1741238460,"startTime":"0","endTime":"0","summary":"能否成为下一个生物医药趋势牛股，且看海豚今日为你深度剖析！微球第一股纳微科技采用耗材+仪器双轮驱动，除了色谱介质外还涉足分析色谱仪、平板显示用微球、体外诊断用微球等领域，相比之下赛分科技则主要聚焦于药物及生物大分子分离纯化液相色谱材料领域。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenswii7959986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","BK1574","09939","159938","000683.SH"],"gpt_icon":0},{"id":"2517904166","title":"徐冠巨代表：及時修訂《國民經濟行業分類》，納入新興產業","url":"https://stock-news.laohu8.com/highlight/detail?id=2517904166","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517904166?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 12:32","pubTimestamp":1741235521,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["09939","BK0239","BK1161","300832","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2517290987","title":"汽車價格戰暫停的信號，可能要來了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517290987","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517290987?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 11:11","pubTimestamp":1741230660,"startTime":"0","endTime":"0","summary":"而提交的5个议案中，只有关于优化新能源车号牌设计的建议出圈，拿下了多数关注。目前2025年关于汽车的相关提案，能提炼出的关键词是，希望全力推进自动驾驶。而2023年，也是汽车价格战真正开打的元年，以雪铁龙C6大降价为真正引爆点的大降价行为，本身是燃油车面对新能源车时竞争力明显下降，落后产能急于出清。从价格战，切换到技术战的信号，已经非常明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306112810989e01fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306112810989e01fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015978.USD","BK1515","LU0449515922.USD","LU0516423174.USD","LU0511384066.AUD","LU0516422366.SGD","LU1868838027.USD","BK1607","BK1540","LU1808992512.USD","LU0054450605.USD","BK1522","LU0274383008.USD","00285","LU2097828805.USD","LU0856984785.SGD","LU2097828631.EUR","002594","BK1119","01211","LU0417516738.SGD","LU0348766576.USD","BK1610","LU0708995583.HKD","BYDDY","LU0320764599.SGD","LU0823426308.USD","LU1023057109.AUD","SG9999006597.SGD","LU1861214812.USD","LU0819123356.HKD","HYDD.SI","LU0254981946.USD","LU0307460666.USD","LU2476274308.USD","LU1242518857.USD","LU2348774022.SGD","LU0359202008.SGD","81211","BK1589","BK1509","LU0143863198.USD","LU0593848301.USD","LU0449509016.USD","SG9999015945.SGD","LU0516422952.EUR","LU2778985437.USD","LU2360107325.USD","BK1504","BK1580"],"gpt_icon":1},{"id":"2517051689","title":"復星醫藥(02196)1類肺癌新藥申報上市 顱內客觀緩解率可達100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517051689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517051689?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:55","pubTimestamp":1741229701,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月6日，中国国家药监局药品审评中心官网最新公示，复星医药成员企业复星万邦申报的1类新药丁二酸复瑞替尼胶囊的上市申请获得受理。在该研究中，复瑞替尼治疗基线脑转移的ALK阳性晚期NSCLC患者，颅内客观缓解率可达到100%。图片来源：CDE官网根据复星医药此前公布的研究结果，从2020年12月至2022年3月，该研究共招募275例患者，其中139例接受复瑞替尼治疗，136例接受对照药治疗。截至2024年3月，中位随访时间为16.7个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0187","BK0060","BK0188","BK1515","BK0012","BK0028","600196","BK0096","BK0183","BK1593","02196","BK0239","BK1191","BK0175"],"gpt_icon":0},{"id":"2517055009","title":"京東健康盤中異動 早盤快速上漲3.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517055009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517055009?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:50","pubTimestamp":1741229447,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时50分，京东健康股票出现异动，股价大幅上涨3.10%。截至发稿，该股报39.850港元/股，成交量1228.75万股，换手率0.38%，振幅4.53%。京东健康股票所在的药品分销行业中，整体涨幅为0.36%。其相关个股中，叮当健康、大健康国际、京东健康涨幅较大，振幅较大的相关个股有叮当健康、金活医药集团、澳至尊，振幅分别为5.15%、4.88%、4.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105047abea8f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105047abea8f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1591","BK1589","06618","BK1583","LU0456827905.SGD","BK1515","LU0051755006.USD","BK1247","BK1142","86618","BK1571"],"gpt_icon":0},{"id":"2517055799","title":"港股創新藥ETF漲超2.5%，來凱醫藥-B漲超11%，機構：具有高科技屬性的醫藥醫療公司將更受市場青睞","url":"https://stock-news.laohu8.com/highlight/detail?id=2517055799","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517055799?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:35","pubTimestamp":1741228542,"startTime":"0","endTime":"0","summary":"相关ETF方面，港股创新药ETF截至发稿涨2.52%，成交额超1亿元，换手率超20%，盘中交投活跃。港股创新药ETF紧密跟踪港股通创新药指数，该指数反映港股通生物科技产业上市公司的运行特征。财通证券表示，看多创新药政策新周期带来的产业链共振上升，看多AI对医药产业带来的中长期影响，具有高科技属性的医药医疗公司将更受市场青睐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306104204a261a137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306104204a261a137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02105","09939","BK1515"],"gpt_icon":0},{"id":"2517908031","title":"港股異動 | 歌禮制藥-B(01672)漲超5% ASC30、ASC47均具備差異化設計方式 產品發展未來可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908031","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908031?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:22","pubTimestamp":1741227746,"startTime":"0","endTime":"0","summary":"中信建投发布研报称，歌礼制药-B发布公告，其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示，前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。该行认为，全球减重药物市场规模蓬勃成长，众多超重或肥胖成年人群急需创新药物来改善并提高生活质量，在此基础下，公司的两款药物ASC30、ASC47均具备差异化设计方式，产品发展未来可期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1515","01477","BK1161","BK1574","01672"],"gpt_icon":0}],"pageSize":16,"totalPage":35,"pageCount":1,"totalSize":555}]}}